HK1045945B - 稳定的丁苄唑啉和氧甲唑啉溶液 - Google Patents

稳定的丁苄唑啉和氧甲唑啉溶液 Download PDF

Info

Publication number
HK1045945B
HK1045945B HK02107497.1A HK02107497A HK1045945B HK 1045945 B HK1045945 B HK 1045945B HK 02107497 A HK02107497 A HK 02107497A HK 1045945 B HK1045945 B HK 1045945B
Authority
HK
Hong Kong
Prior art keywords
solution according
active metal
solution
ions
weight
Prior art date
Application number
HK02107497.1A
Other languages
English (en)
Chinese (zh)
Other versions
HK1045945A1 (en
Inventor
弗里德‧U‧梅尔兹
弗里德‧U‧梅爾茲
Original Assignee
贝林格尔‧英格海姆国际有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23322017&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1045945(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 贝林格尔‧英格海姆国际有限公司 filed Critical 贝林格尔‧英格海姆国际有限公司
Publication of HK1045945A1 publication Critical patent/HK1045945A1/xx
Publication of HK1045945B publication Critical patent/HK1045945B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/38Silver; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Cosmetics (AREA)
HK02107497.1A 1999-06-22 2000-06-17 稳定的丁苄唑啉和氧甲唑啉溶液 HK1045945B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33778999A 1999-06-22 1999-06-22
US09/337,789 1999-06-22
PCT/EP2000/005583 WO2000078297A2 (de) 1999-06-22 2000-06-17 Stabile xylometazolin- und oxymetazolinlösung

Publications (2)

Publication Number Publication Date
HK1045945A1 HK1045945A1 (en) 2002-12-20
HK1045945B true HK1045945B (zh) 2005-01-28

Family

ID=23322017

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107497.1A HK1045945B (zh) 1999-06-22 2000-06-17 稳定的丁苄唑啉和氧甲唑啉溶液

Country Status (22)

Country Link
US (2) US20040191177A1 (https=)
EP (1) EP1194145B1 (https=)
JP (1) JP2003502361A (https=)
KR (1) KR20020012001A (https=)
CN (1) CN1164271C (https=)
AT (1) ATE232099T1 (https=)
AU (1) AU765736B2 (https=)
BR (1) BR0011950A (https=)
CA (1) CA2376121C (https=)
CZ (1) CZ295595B6 (https=)
DE (1) DE50001217D1 (https=)
EA (1) EA003329B1 (https=)
ES (1) ES2188563T3 (https=)
HK (1) HK1045945B (https=)
HU (1) HUP0201700A3 (https=)
IL (1) IL147023A0 (https=)
MX (1) MXPA01012912A (https=)
PL (1) PL197542B1 (https=)
PT (1) PT1194145E (https=)
TR (1) TR200103694T2 (https=)
WO (1) WO2000078297A2 (https=)
ZA (1) ZA200110386B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226527B1 (hu) 2001-09-18 2009-03-30 Nycomed Danmark Aps Készítmények nátha kezelésére
JP2005533076A (ja) * 2002-06-20 2005-11-04 ノバルテイス・コンシユーマー・ヘルス・エス・アー ムコ多糖及びプロピレングリコールを含む鼻用組成物
WO2004024187A2 (en) * 2002-09-13 2004-03-25 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
DE10337186A1 (de) * 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
US20090136598A1 (en) * 2006-04-26 2009-05-28 Aciex, Inc. Compositions for the Treatment and Prevention of Eyelid Swelling
JP2009535342A (ja) * 2006-04-26 2009-10-01 アーシエックス, インコーポレイテッド 眼瞼腫脹の予防および処置のための組成物
CN101912363A (zh) * 2010-07-29 2010-12-15 蔡海德 溶解超滤-喷雾干燥-分子分散包衣-水化制粒-冷冻干燥生产脂质体组合药物
PL3236933T3 (pl) 2014-12-24 2019-05-31 Jadran Galenski Laboratorij D D Kompozycja do podawania donosowego zawierająca wodę morską jako zaróbkę poprawiającą trwałość
EP4404916B1 (en) 2021-09-22 2025-08-06 JADRAN - GALENSKI LABORATORIJ d.d. An improved pharmaceutical composition for nasal use, preparation, and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603131A (en) * 1982-04-26 1986-07-29 Bernstein Joel E Method and composition for treating and preventing irritation of the mucous membranes of the nose
US5114979A (en) * 1989-10-18 1992-05-19 Schering Corporation Fruity flavored nasal decongestant composition
US4970240A (en) * 1989-10-18 1990-11-13 Schering Corporation Fruity flavored nasal decongestant composition
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
DE19549421C2 (de) * 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
DE19542959C1 (de) * 1995-11-17 1996-10-24 Ursatec Verpackung Gmbh Vor Kontamination schützende Abgabevorrichtung für Fluide
EP0861128B1 (de) * 1995-11-17 2003-02-19 Ursatec Verpackung Gmbh Vor kontamination schützende abgabevorrichtung für fluide
DK1051155T3 (da) * 1998-01-30 2002-09-16 Novartis Consumer Health Sa Nasale opløsninger

Also Published As

Publication number Publication date
ZA200110386B (en) 2003-04-22
CA2376121C (en) 2008-06-10
PL352354A1 (en) 2003-08-11
BR0011950A (pt) 2002-03-12
PL197542B1 (pl) 2008-04-30
AU765736B2 (en) 2003-09-25
EA003329B1 (ru) 2003-04-24
DE50001217D1 (de) 2003-03-13
CA2376121A1 (en) 2000-12-28
US20080011293A1 (en) 2008-01-17
CN1164271C (zh) 2004-09-01
HUP0201700A2 (hu) 2002-12-28
CZ295595B6 (cs) 2005-08-17
EA200200042A1 (ru) 2002-06-27
HK1045945A1 (en) 2002-12-20
KR20020012001A (ko) 2002-02-09
ES2188563T3 (es) 2003-07-01
MXPA01012912A (es) 2002-09-18
PT1194145E (pt) 2003-06-30
EP1194145A2 (de) 2002-04-10
US20040191177A1 (en) 2004-09-30
JP2003502361A (ja) 2003-01-21
CZ20014568A3 (cs) 2002-03-13
TR200103694T2 (tr) 2002-04-22
CN1361689A (zh) 2002-07-31
ATE232099T1 (de) 2003-02-15
EP1194145B1 (de) 2003-02-05
WO2000078297A2 (de) 2000-12-28
AU6150600A (en) 2001-01-09
WO2000078297A3 (de) 2001-03-01
IL147023A0 (en) 2002-08-14
HUP0201700A3 (en) 2003-02-28

Similar Documents

Publication Publication Date Title
CN1133432C (zh) 含水液体药物组合物
CN1145491C (zh) 用作抗微生物剂的酸化亚硝酸盐
CN1121232C (zh) 治疗疱疹的药物组合物
CN1130204C (zh) 具有抗微生物活性的药物组合物
CN1679472A (zh) 抗真菌指甲油组合物
CN1055874A (zh) 眼药水溶液和使该溶液防腐的方法
CN1223546A (zh) 单纯性疱疹病毒和其它感染性疾病的抗微生物疗法
HK1045945A1 (en) Stable xylometazoline and oxymetazoline solution
EP1755576B1 (en) Antimicrobial compositions and methods for their use
US20220304916A1 (en) Modified black soldier fly larvae oil with modified lauric acid for treatment against biofilm formation and microorganism growth
CN1137220A (zh) 含有季铵盐的低毒性的杀菌剂
US11331289B2 (en) Antimicrobial composition
CN1143324A (zh) 治疗皮肤病的新药物组合物
CN1203892C (zh) α-干扰素水性溶液制剂
US20090081153A1 (en) Combination of synthetic antimicrobial polymers and sesquiterpenoid compounds
CN1135179A (zh) 作为独特治疗剂的羟离子和调节这些离子的化合物,使用这些制剂的组合物,应用这类制剂的治疗方法和它们的制备方法
US12465059B2 (en) Concentrated formic acid composition and its uses thereof
CN1216532C (zh) 稳定的异噻唑酮组合物和稳定异噻唑酮的方法
CN1374874A (zh) 使用脂肪酸/氨基酸皂类提高局部药物组合物的抗菌效力
CN102215819B (zh) 具有相对低的离子强度的药物组合物
KR20070043841A (ko) 피페라진 유도체의 약제 조성물
FR2614788A1 (fr) Composition pharmaceutique a activite antiseptique
US20210100769A1 (en) Preservative-free formulations of tetracaine hcl
AU2005230209B2 (en) Antimicrobial compositions and methods for their use

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100617